-
1
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
doi: 10.1056/NEJMoa043330
-
Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
-
(2005)
N Engl J Med
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
-
2
-
-
1442283179
-
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: Toxicity with therapeutic implications
-
doi: 10.1200/JCO.2004.07.060
-
Su YB, Sohn S, Krown SE, Livingston PO, Wolchok JD, Quinn C et al (2004) Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: Toxicity with therapeutic implications. J Clin Oncol 22(4):610-616. doi: 10.1200/JCO.2004.07.060
-
(2004)
J Clin Oncol
, vol.22
, Issue.4
, pp. 610-616
-
-
Su, Y.B.1
Sohn, S.2
Krown, S.E.3
Livingston, P.O.4
Wolchok, J.D.5
Quinn, C.6
-
3
-
-
34347405488
-
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide
-
doi: 10.1080/07357900701206380
-
Schwarzberg AB, Stover EH, Sengupta T, Michelini A, Vincitore M, Baden LR et al (2007) Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 25(4):249-255. doi: 10.1080/07357900701206380
-
(2007)
Cancer Invest
, vol.25
, Issue.4
, pp. 249-255
-
-
Schwarzberg, A.B.1
Stover, E.H.2
Sengupta, T.3
Michelini, A.4
Vincitore, M.5
Baden, L.R.6
-
4
-
-
23044508156
-
How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience
-
doi: 10.1200/JCO.2004.00.8417 author reply 4236
-
Wick W, Weller M (2005) How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience. J Clin Oncol 23(18):4235-4236. doi: 10.1200/JCO.2004.00.8417 author reply 4236
-
(2005)
J Clin Oncol
, vol.23
, Issue.18
, pp. 4235-4236
-
-
Wick, W.1
Weller, M.2
-
5
-
-
0025761357
-
Pneumocystis carinii pneumonia in patients with primary brain tumors
-
Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48(4):406-409
-
(1991)
Arch Neurol
, vol.48
, Issue.4
, pp. 406-409
-
-
Henson, J.W.1
Jalaj, J.K.2
Walker, R.W.3
Stover, D.E.4
Fels, A.O.5
-
6
-
-
17044394716
-
Global epidemiology of tuberculosis
-
doi: 10.1016/j.ccm.2005.02.009
-
Maher D, Raviglione M (2005) Global epidemiology of tuberculosis. Clin Chest Med 26(2):167-182. doi: 10.1016/j.ccm.2005.02.009
-
(2005)
Clin Chest Med
, vol.26
, Issue.2
, pp. 167-182
-
-
Maher, D.1
Raviglione, M.2
-
7
-
-
33646740188
-
The risk of tuberculosis in patients with cancer
-
doi: 10.1086/503917
-
Kamboj M, Sepkowitz KA (2006) The risk of tuberculosis in patients with cancer. Clin Infect Dis 42(11):1592-1595. doi: 10.1086/503917
-
(2006)
Clin Infect Dis
, vol.42
, Issue.11
, pp. 1592-1595
-
-
Kamboj, M.1
Sepkowitz, K.A.2
-
8
-
-
22144485870
-
Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection
-
doi: 10.1016/j.ijrobp.2004.12.085
-
Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62(5):1423-1426. doi: 10.1016/ j.ijrobp.2004.12.085
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, Issue.5
, pp. 1423-1426
-
-
Hughes, M.A.1
Parisi, M.2
Grossman, S.3
Kleinberg, L.4
-
9
-
-
0001489523
-
This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC)
-
Targeted tuberculin testing and treatment of latent tuberculosis infection
-
Targeted tuberculin testing and treatment of latent tuberculosis infection (2000). This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med 161:S221
-
(2000)
Am J Respir Crit Care Med
, vol.161
-
-
-
10
-
-
0034486505
-
Pure red cell aplasia
-
doi: 10.1046/j.1365-2141.2000.02429.x
-
Fisch P, Handgretinger R, Schaefer HE (2000) Pure red cell aplasia. Br J Haematol 111(4):1010-1022. doi: 10.1046/j.1365-2141.2000.02429.x
-
(2000)
Br J Haematol
, vol.111
, Issue.4
, pp. 1010-1022
-
-
Fisch, P.1
Handgretinger, R.2
Schaefer, H.E.3
-
11
-
-
0029835504
-
Drug-induced pure red cell aplasia
-
Thompson DF, Gales MA (1996) Drug-induced pure red cell aplasia. Pharmacotherapy 16(6):1002-1008
-
(1996)
Pharmacotherapy
, vol.16
, Issue.6
, pp. 1002-1008
-
-
Thompson, D.F.1
Gales, M.A.2
-
12
-
-
34848837735
-
Pure red blood cell aplasia and isoniazid use
-
Loulergue P, Mir O, Dhote R (2007) Pure red blood cell aplasia and isoniazid use. Emerg Infect Dis 13(9):1427-1428
-
(2007)
Emerg Infect Dis
, vol.13
, Issue.9
, pp. 1427-1428
-
-
Loulergue, P.1
Mir, O.2
Dhote, R.3
-
14
-
-
0033015149
-
Remission of pure-red-cell aplasia associated with operative cure of lung cancer
-
doi:10.1002/(SICI)1096-8652(199906)61:2<157::AID-AJH20>3.0.CO;2-8
-
Tauchi T (1999) Remission of pure-red-cell aplasia associated with operative cure of lung cancer. Am J Hematol 61(2):157-158. doi:10.1002/ (SICI)1096-8652(199906)61:2<157::AID-AJH20>3.0.CO;2-8
-
(1999)
Am J Hematol
, vol.61
, Issue.2
, pp. 157-158
-
-
Tauchi, T.1
-
15
-
-
0020535292
-
Acquired pure red cell aplasia associated with thyroid carcinoma: Case report
-
Iannucci A (1983) Acquired pure red cell aplasia associated with thyroid carcinoma: Case report. Acta Haematol 69(1):62-63
-
(1983)
Acta Haematol
, vol.69
, Issue.1
, pp. 62-63
-
-
Iannucci, A.1
-
16
-
-
30944449601
-
Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate
-
doi: 10.1111/j.1442-2042.2005.01195.x
-
Kobayashi M (2005) Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate. Int J Urol 12(11):1010-1011. doi: 10.1111/j.1442-2042.2005.01195.x
-
(2005)
Int J Urol
, vol.12
, Issue.11
, pp. 1010-1011
-
-
Kobayashi, M.1
-
17
-
-
34047197993
-
Fatal hematologic toxicity with prolonged continuous administration of temozolomide during radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: Report of a phase II trial
-
Abstract
-
Doyle TJ, Mikkelsen T, Croteau D et al (2005) Fatal hematologic toxicity with prolonged continuous administration of temozolomide during radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: Report of a phase II trial. Proc Am Soc Clin Oncol 23:125S. Abstract
-
(2005)
Proc Am Soc Clin Oncol
, vol.23
-
-
Doyle, T.J.1
Mikkelsen, T.2
Croteau, D.3
-
18
-
-
33646002315
-
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide
-
doi: 10.1016/S1470-2045(06)70696-9
-
Villano JL, Collins CA, Manasanch EE, Ramaprasad C, van Besien K (2006) Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 7(5):436-438. doi: 10.1016/ S1470-2045(06)70696-9
-
(2006)
Lancet Oncol
, vol.7
, Issue.5
, pp. 436-438
-
-
Villano, J.L.1
Collins, C.A.2
Manasanch, E.E.3
Ramaprasad, C.4
van Besien, K.5
-
19
-
-
34548710872
-
Unexpected case of aplastic anaemia in a patient with glioblastoma multiforme treated with temozolomide
-
doi: 10.1007/s11060-007-9398-z
-
Jalali R, Singh P, Menon H, Gujral S (2007) Unexpected case of aplastic anaemia in a patient with glioblastoma multiforme treated with temozolomide. J Neurooncol 85(1):105-107. doi: 10.1007/s11060-007-9398-z
-
(2007)
J Neurooncol
, vol.85
, Issue.1
, pp. 105-107
-
-
Jalali, R.1
Singh, P.2
Menon, H.3
Gujral, S.4
|